The growing potential of tofacitinib in immune checkpoint inhibitor-induced colitis: identifying remaining puzzle pieces
Immunotherapy, a primary anti-neoplastic treatment, exploits the patient’s immune system to kill neoplastic cells by modulating immune checkpoints such as cytotoxic T-lymphocyte antigen 4 and programmed cell death 1. Despite an apparent anti-neoplastic efficacy, immunotherapeutic agents are often ac...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Open Exploration Publishing Inc.
2024-11-01
|
| Seri Bilgileri: | Exploration of Immunology |
| Konular: | |
| Online Erişim: | https://www.explorationpub.com/Journals/ei/Article/1003171 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|